First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke).
(Clinical Trial;Journal Article;Multicenter Study)
BACKGROUND AND PURPOSE: Acute revascularization is associated with improved outcomes in ischemic stroke patients. However, it is unclear which method of intraarterial intervention, if any, is ideal. Numerous case series and cardiac literature parallels suggest that acute stenting may yield high revascularization levels with low associated morbidity. We therefore conducted a Food and Drug Administration-approved prospective pilot trial to evaluate the safety of intracranial stenting for acute ischemic stroke. METHODS: Eligibility criteria included presentation or=8, angiographic demonstration of focal intracerebral artery occlusion
Levy, EI; Siddiqui, AH; Crumlish, A; Snyder, KV; Hauck, EF; Fiorella, DJ; Hopkins, LN; Mocco, J
Volume / Issue
Start / End Page
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)